MR

Maulik R Joshi

Active Director Director DIN 07033823
DIN 07033823 First appointment Jul 2024 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2024
Shareholding value •••• Premium profile

About Maulik R Joshi

Data last updated:

Maulik R Joshi is a Director at Krosyl Pharmaceuticals Private Limited (since 2024). The company operates in Pharma. Krosyl Pharmaceuticals Private Limited reported revenue of ₹6.32 Cr (FY 2024).

DIN 07033823
Primary Designation Director
Industry Pharma
First Appointment 30 Jul 2024
Oldest Company Age 11 yrs
Largest company Krosyl Pharmaceuticals Private Limited · ₹6.32 Cr (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director30 Jul 20242015₹6.32 Cr (FY 2024)Active

Directorship timeline

Open interactive timeline →
Krosyl Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Maulik R Joshi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Maulik R Joshi

Maulik R Joshi currently holds 1 directorship: Krosyl Pharmaceuticals Private Limited (Director, since 30 Jul 2024, revenue ₹6.32 Cr (FY 2024)).

Maulik R Joshi was first appointed on 30 Jul 2024 as Director at Krosyl Pharmaceuticals Private Limited.

The current boards of Maulik R Joshi's companies include Amit Prabhudas Patel (Krosyl Pharmaceuticals Private Limited), Nilesh Prajapati (Krosyl Pharmaceuticals Private Limited), Parth Rameshkumar Joshi (Krosyl Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available